Company news
Collplant Biotechnologies Ltd. (NASDAQ:CLGN) news
Every Collplant Biotechnologies Ltd. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases — page 2
CollPlant Issues Letter to Shareholders
February 14, 2024
CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California
January 7, 2024
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
January 1, 2024
CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023
November 28, 2023
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
November 8, 2023
CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler
October 31, 2023
CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative
September 20, 2023
CollPlant to Present at the H.C. Wainwright Annual Growth Conference
September 4, 2023
CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million
August 23, 2023
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
August 8, 2023
CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration Agreement
June 25, 2023
CollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate Update
May 23, 2023
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
May 1, 2023
BioHarvest Sciences Hires Dr. Ilana Belzer as Chief Operating Officer
April 18, 2023
Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs
April 3, 2023
Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate Update
March 28, 2023
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
March 13, 2023
CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of Objectives
January 3, 2023
CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder Form
January 2, 2023
CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial Results
November 30, 2022
CollPlant, Tel Aviv University and Sheba Medical Center Join Forces to Co-Develop rhCollagen-Based 3D Bioprinted Human Intestine Model for Drug Discovery and Personalized Treatment of Ulcerative Colitis
November 14, 2022
CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3D™ 90
November 6, 2022
CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17
November 2, 2022
CollPlant to present at the Dawson James Small Cap Growth Conference on October 12
October 2, 2022
CollPlant to Present at the International Conference on Biofabrication 2022 in Tuscany, Italy
September 18, 2022
CollPlant Biotechnologies to Participate in September Investor Conferences
September 5, 2022
CollPlant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial Results
August 24, 2022
CollPlant to Present and Exhibit at TERMIS Annual Conference in Toronto, Canada
July 4, 2022
CollPlant Advances its 3D Bioprinted Regenerative Breast Implants into Porcine Study
June 27, 2022
CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial Results
May 25, 2022
CollPlant CEO Yehiel Tal to Moderate ISBF's virtual event on Biofabrication of Microphysiological Systems for Drug Discovery and Screening
April 24, 2022
CollPlant To Present at the Aesthetics Innovation Summit 2022
April 12, 2022
CollPlant Biotechnologies Provides Business Updates and Fiscal Year 2021 Financial Results
March 23, 2022
CELLINK and CollPlant Enter a Collaboration Agreement to Explore Future Large-Scale Production of CollPlant's Regenerative Breast Implants using CELLINK's Bioprinting technologies
February 15, 2022
CollPlant Announces Publication Highlighting its rhCollagen-based Photocurable Dermal Filler in the Plastic and Reconstructive Surgery Journal
December 1, 2021
CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial Results
November 17, 2021
CollPlant Announces Commercial Launch of BioInk Platform with Collink.3D™ for Use in 3D Bioprinting of Human Tissues, Scaffolds and Organs
November 14, 2021
CollPlant to Present at Dawson James Small Cap Growth Conference on October 21st
October 13, 2021
CollPlant's rhCollagen BioInk Used by Technion Researchers to Develop 3D Bioprinted Vascularized Tissue Constructs
October 10, 2021
CollPlant to Present at Fall Harvest - Best Ideas from the Buy-Side on October 5, 2021
September 29, 2021
CollPlant CEO Yehiel Tal to Discuss Emerging Uses of rhCollagen in Aesthetic and Regenerative Medicine at NANO.IL.2021 Conference
September 26, 2021
CollPlant CEO Yehiel Tal elected to the Board of Directors of the International Society for Biofabrication (ISBF)
September 8, 2021
CollPlant To Present at the H.C. Wainwright Annual Global Investment Conference in September
September 6, 2021
CollPlant Biotechnologies Provides Business Updates and Second Quarter 2021 Financial Results
August 18, 2021
CollPlant Appoints Medical Aesthetics Veteran Alisa Lask to Board of Directors
August 18, 2021
CollPlant Biotechnologies to Present on the Use of Collagen BioInk as a Platform for 3D Bioprinting of Tissues and Organs at the Biomaterials For 3D Printing Webinar
August 15, 2021
3D Systems and CollPlant Enter Co-development Agreement to Deliver Bioprinted Solutions for Improved Breast Reconstruction Treatments
June 21, 2021
CollPlant Announces Effectiveness of Uplisting to the Nasdaq Global Market®; Ordinary Shares Replace ADSs
June 3, 2021
CollPlant Biotechnologies Reports First Quarter 2021 Financial Results with Record Revenues of $14.5 Million
May 26, 2021
CollPlant Announces Uplisting to the Nasdaq Global Market® and Transition to Trading of Ordinary Shares Instead of ADSs
May 24, 2021